Under the terms of the agreement, Pfizer is expected to pay an upfront total of $30 million in early 2026 to Novavax, while ...
Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
InvestorsHub on MSN
Novavax shares gain after Matrix-M adjuvant licensing deal with Pfizer
Novavax (NASDAQ:NVAX) shares climbed about 5% on Tuesday after the biotech group disclosed a non-exclusive licensing ...
The agreement allows Pfizer to utilize Novavax’s Matrix-M adjuvant in up to two disease areas with its products. Under the terms of the deal, Novavax will receive an upfront payment of $30 million and ...
The new Audi Q3 sets new standards in headlight development with lighting technology from ZKW. The technological highlights of the compact SUV include the digital Matrix LED headlights, which are ...
Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 19.7% in the afternoon session after the company ...
Thiruvananthapuram | SCTIMST on Thursday said it has fabricated what it claims is the "world's first tissue graft scaffold" ...
Novavax, Inc. (Nasdaq: NVAX) has entered into a license agreement with Pfizer for use of Novavax's Matrix-M® adjuvant. Under the terms of the agreement, Pfizer will obtain a non-exclusive license for ...
SCTIMST on Thursday said it has fabricated what it claims is the “world’s first tissue graft scaffold” from the gall bladder ...
Initiative focuses on the design, simulation and testing of a carbon fiber yacht mast, seeking to replace traditional ...
MarketNsight, a leading housing data research and consulting firm, announced the appointment of Eugene James as its new ...
Thiruvananthapuram: The Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) announced on Thursday ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果